The acquisition will be carried out for a cash consideration of $16.50 million, subject to customary adjustments.

Founded in 1999, Unbound Medicine provides digital medical reference tools, clinical decision-support solutions and healthcare learning platforms. Its services are delivered through proprietary mobile and web-based platforms and follow a subscription-led institutional business model. The company serves medical schools, hospital systems and healthcare associations across the United States and Canada.

MPS said the acquisition aligns with its strategy of building platform-led, recurring-revenue businesses. The transaction is expected to support revenue diversification, enable cross-selling opportunities and strengthen the company’s presence in the North American market.

MPS provides learning and platform solutions combining content, technology and artificial intelligence. The company is focused on scaling operations and strengthening its position in the global learning and knowledge services market.

On a consolidated basis, net profit of MPS rose 57.32% to Rs 55.44 crore while net sales rose 9.42% to Rs 194.44 crore in Q2 September 2025 over Q2 September 2024.